Timing of Endoscopy for Acute Variceal Bleeding in Patients With Cirrhosis

Hepatopancreatobiliary Surgery Institute of Gansu Province

Status

Completed

Conditions

Portal Hypertension

Cirrhosis, Liver

Varice Bleed

Treatments

Device: emergency endoscopic therapy

Study type

Observational

Funder types

Other

Identifiers

NCT04957875

CHESS1905

Details and patient eligibility

About

Cirrhotic patients with AVB across 34 university medical centers in 30 cities in China from February 2013 to May 2020 who underwent endoscopy within 24 hours were included in this study. Patients were divided into an urgent endoscopy group (endoscopy <6h after admission) and an early endoscopy group (endoscopy 6-24h after admission). Outcomes included the incidence of 5-day rebleeding, in-hospital mortality, need for intensive care unit (ICU) and the length of hospital stay after the endoscopy management. Multivariable analysis was performed to identify risk factors for rebleeding. A propensity score matching (PSM) analysis was performed to achieve a balance at baseline between the urgent and early groups.

Enrollment

3,300 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

established diagnosis of cirrhosis (based on liver biopsy or the combination of clinical, biochemical, and imaging findings)
witnessed or reported evidence of gastrointestinal haemorrhage (hematemesis, melenemesis, or hematochezia)
esophageal or gastric varices confirmed endoscopically as the source of bleeding

Exclusion criteria

severe dysfunction of a major extrahepatic organ (e.g., heart failure, pulmonary disease, and terminal malignancy except hepatocellular carcinoma)
history of endoscopic therapy for varices (ligation or sclerotherapy) within three months
incomplete or missing data